It shows that in the Q3 group, participants generally had a higher incidence of GDM and NAFLD; higher levels of BMI, GGT, TG, LDL, insulin, and HOMA-IR; and lower HDL levels. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.